je.st
news
Tag: value
Is Range Resources A Value Trap?
2015-09-09 16:23:55| Oil & Gas - Topix.net
The enjoyment of investment research, at least for me, is that the combination of intellectual curiosity, Google's search engine, and time are the only inputs required to acquire new knowledge and gather important clues required to build a strong investment case. On a recent mini investment research odyssey, well adrift at sea, I was able to find enough information that led me to produce this write up on Range Resources .
Tags: range
resources
value
trap
CF Industries - A Long-Term Play For DGI'ers, Growth And Value Investors Alike
2015-09-01 02:47:42| Agriculture - Topix.net
A merger with rival OCI and a strategic partnership with CHS, Inc. positions CF Industries as the world's largest publicly traded fertilizer manufacturer. CF Industries trades at a discount to its competitors and the S&P 500, and has a history of robust dividend growth with a low payout ratio.
Tags: play
value
growth
industries
CF Industries - A Long-Term Play For DGI'ers, Growth And Value Investors Alike
2015-09-01 02:08:51| Chemicals - Topix.net
A merger with rival OCI and a strategic partnership with CHS, Inc. positions CF Industries as the world's largest publicly traded fertilizer manufacturer. CF Industries trades at a discount to its competitors and the S&P 500, and has a history of robust dividend growth with a low payout ratio.
Tags: play
value
growth
industries
SoftBank's buying adds $6.7 billion to Sprint's value
2015-09-01 00:06:58| IT Services - Topix.net
New York a SoftBank Group's spree of buying Sprint Corp. stock has boosted the struggling U.S. wireless carrier by 50 percent over the past two weeks, adding $6.7 billion to its market value. As of last Friday, the Japanese company had purchased Sprint shares every day since Aug. 10, increasing its stake to 82 percent, according to a filing with the U.S. Securities & Exchange Commission.
Tags: value
buying
billion
adds
Study: Cancer drugs aren't just really expensive; they're a bad value
2015-08-28 15:03:46| Biotech - Topix.net
A study published Thursday in JAMA Oncology aims to answer that question by examining necitumumab, an experimental lung cancer drug made by Eli Lilly & Co. The drug isn't approved yet, and Eli Lilly has not set a price.
Sites : [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] next »